Human-centred innovation in a digital world.
Paul Hobcraft
APRIL 19, 2021
Already most of the major pharmaceutical or biotechnology companies had some levels of vaccine platform technologies. Just announced is the collaborative work that Siemens has been doing with BioNTech, getting involved in converting existing facilities in Germany to produce the mRNA-vaccine project. Opinions are my own.
Let's personalize your content